by

The COVID-19 Task Force reports a third dose of 25.44 percent as of Wednesday

Jakarta, The Indonesia Post – The COVID-19 Handling Task Force reported that as of Wednesday, the rate of injection of the third dose or first booster vaccine had been given to 25.44 percent of the total population targeted for COVID-19 vaccination, namely 234,666,020 people.

The press release of the COVID-19 Task Force received in Jakarta, Wednesday, showed that the number of residents who had received the three doses of the COVID-19 vaccine increased by 59,308 people to 59,717,885 people.

Meanwhile, the population who received two doses of the COVID-19 vaccine increased by 23,628 people to 170,751,095 people, equivalent to 72.76 percent of the total target.

While the recipients of the first dose increased by 14,665 people so that it reached 203,161,073 people or equivalent to 86.57 percent of the total target.

Meanwhile, the recipients of the fourth dose or the second booster vaccine increased by 548 people to become 279,574 people.

On Wednesday, the Task Force noted that there were an addition of 5,428 COVID-19 cases in Indonesia, 5,550 recovered patients and 18 patients died from COVID-19.

Nationally, the number of active cases fell by 140 cases to 48,363 active cases.

The Ministry of Health is currently deepening the study of administering the COVID-19 vaccine to vulnerable groups who have not been able to participate in vaccination.

The study included the elderly and comorbid patients.

The plan is to give vaccinations to the group with low antibodies to start at the end of 2022. In addition, the government is increasing the dose of the COVID-19 vaccine for the elderly and comorbid groups according to their names and places of residence.

This is continuously being pursued so that the antibodies that are currently owned by the community are still formed after the antibodies of a number of parties have decreased due to more than six months of not carrying out further vaccinations.

“We will immediately provide an alternative to existing vaccines so that they can increase their immunity levels, to maintain the level of immunity of the Indonesian population, to face or be prepared in early next year if for example there is a new variant,” said Health Minister Budi Gunadi Sadikin. (ojn/bbs)

Comment

Leave a Reply

Your email address will not be published. Required fields are marked *